Researchers have long known that the risk for schizophrenia is inherited. In new findings published online Sept 15 in The American Journal of Psychiatry, senior investigator C. Robert Cloninger, MD, PhD, of the Washington University School of Medicine in St. Louis, MO, said his team identified distinct gene clusters that contribute to 8 different classes of the disease.
Taking human pluripotent stem cells, reprogramming them to act like embryonic stem cells, and then getting those cells to create neurons has enabled researchers to create a “brain in a dish.”
In a dramatic demonstration of this technique’s potential in neurological research, scientists recently took some of these neurons and reprogrammed them by using genetic material in skin cells taken from people with schizophrenia.
The new consumer retail market in U.S. healthcare is necessary and will benefit consumers, and as consumers take on more costs of care, access to information to help them make informed decisions is crucial, according to a recent white paper published by Vitals.
Mechanisms underlying nicotine use as a gateway to cocaine use have been proposed in a Shattuck lecture published in the Sept. 4 issue of the New England Journal of Medicine.
Adding an antipsychotic medication, such as risperidone, to stimulant therapy and parent training may improve parent ratings for behavioral problems in children with attention-deficit/hyperactivity disorder, according to research published in the September issue of the Journal of the American Academy of Child & Adolescent Psychiatry.
Many young adult nonmedical prescription opioid (PO) users are relatively uninformed about overdose awareness, avoidance, and response strategies, according to a study published online Aug. 22 in The International Journal of Drug Policy.